International Consolidated Companies, Inc. (INCC) announced today it entered into an exclusive license agreement with CBD Medicinals,

International Consolidated Companies, Inc. (INCC) Enters Into an Exclusive License Agreement for a CBD

INCC Enters Into an Exclusive License Agreement for a CBD Formulation Focused on Enhancing Cognitive Function in Adults

 

BUZ INVESTORS  PRESS RELEASE  International Consolidated Companies, Inc. (INCC) announced today it entered into an exclusive license agreement with CBD Medicinals, LLC for a patent application and trade secrets surrounding the development of an over the counter cannabidiol (CBD) formulation to improve cognitive function in adults.

This technology included novel combinations of CBD, mushroom derived hericenones, and neurotransmitter precursors. Both hericenones and CBD are known to have neuro-protective and neuro-regenerative effects in vivo.

“This will allow us to develop designer CBD products focused on niche markets where the demand is high,” said Antonio Uccello, President INCC.

International Consolidated Companies (INCC) was founded in 2002. INCC is focused on acquiring and producing innovative, high quality, and cost-efficient cannabis technologies.




 International Consolidated Companies

Forward-looking disclaimer

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material may contain statements about expected future events and/or financial results that are forward-looking in nature and subject to risk and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements to be materially different from the statements made herein.

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




BUZ INVESTORS GRWC Wayne Zallen Nasdaq MarketSite Interview Grow Condos, Inc. ( OTCQB : GRWC ), a fully reporting publicly traded company specialized in cannabis industry related “Condo” style real estate and turn-key grow facilities,

$GRWC Wayne Zallen, Featured in Exclusive Nasdaq MarketSite Interview

Grow Condos, Inc. Chief Executive Officer, Wayne Zallen, Featured in Exclusive Nasdaq MarketSite Interview at Times Square

BUZ INVESTORS GRWC Wayne Zallen Nasdaq MarketSite Interview  Grow Condos, Inc. ( OTCQB : GRWC ), a fully reporting publicly traded company specialized in cannabis industry related “Condo” style real estate and turn-key grow facilities,

BUZ INVESTORS GRWC Wayne Zallen Nasdaq MarketSite Interview  Grow Condos, Inc. ( OTCQB : GRWC ), a fully reporting publicly traded company specialized in cannabis industry related “Condo” style real estate and turn-key grow facilities, is pleased to announce that following the Company’s “Smoke on the Water” acquisition, the Company’s Chief Executive Officer, Wayne Zallen was Interviewed at Nasdaq MarketSite at Times Square by Jill Malandrino, Markets Reporter, where he was able to present insight into the Company’s unique position in the industry and corporate vision. The interview can be viewed in its entirety at the NASDAQ site shortly.

Mr. Zallen introduced the Company with a brief overview, reflecting on the various segments of the Company, particularly the corporate real estate division, branding services and financial Services. He proceeded to comment on the statistic revealing that 1 in 5 people or approximately 20% of the US population reside in a legal marijuana state, highlighting market potential for the building of a national footprint. Furthermore, he proceeded to share, based on the Company’s recent “Smoke on the Water” acquisition, that management envisions the building out of a growing number of cannabis friendly destinations. Activities would include yoga, massage, spiritual themes, and amenities would include a general store and the leasing of a dispensary on the property.

OTHER STORIES BUZ TRADERS FOLLOW

GRWC Wayne Zallen Nasdaq MarketSite

In response to an inquiry regarding the Company’s advancement strategy, Mr. Zallen shed light on his ideas regarding the advantage of growth through acquisition. He stated: “The RV industry is very fragmented; full of mom and pop operators, that are basically trading around 3-5% EBITDA, and we’re basically thinking that we can grow this to about 20% EBITDA plus land value. So we see a very fast way to grow our top line in this industry.”

Upon conclusion, in response to Jill’s inquiry regarding his foresight in the political realm and the long-term outlook, he stated: “None of us know what is going to happen with the Trump Administration; that being said, I do think that what’s going on in the industry is that the states that do have legal Marijuana are enjoying the tax benefits from that. I don’t think that they are going to want to see those tax revenues stop. I also think that other states right now are looking at the legal states and thinking that they might want a piece of that pie.” He concluded by eluding to the fact that the analyst projections point to a 50 Billion dollar industry by 2020, giving the Company the ability to develop a substantial national footprint.

Nasdaq MarketSite delivers up-to-the-minute news, break-out events and worldwide media coverage that build knowledge, value and brands. Nasdaq is built strategically around four complementary business segments — Tech, Trade, Intel and List, that guide clients as they pursue opportunities to create, or maximize value in the world’s capital markets. Nasdaq provides the infrastructure, tools and strategic insights tailored for the capital-market opportunities of today and the expectations of tomorrow.

Grow Condos, Inc. recently announced the successful acquisition of one of the territory’s privately owned nature rich vacation spots, Lake Selmac Resort & RV Park, situated in the picturesque heart of Southern Oregon. Located just 20 miles south of Grants Pass, Oregon and 2.5 miles east of the Redwood Highway (Hwy. 199) in Selma, Oregon, Lake Selmac Resort the peaceful exclusive property currently facilitates Fishing, Swimming, Boating, and in addition to RV parking, has Tent Camping & Cabin locations established for accommodation. To view more regarding the property, visit: http://www.lakeselmac.com. Shareholders will be kept updated as events continue to unfold.

About Nasdaq: Nasdaq (NASDAQ:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables clients to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 85 marketplaces in 50 countries, and 1 in 10 of the world’s securities transactions. Nasdaq is home to approximately 3,800 listed companies with a market value of $10.1 trillion and nearly 18,000 corporate clients. To learn more, visit: business.nasdaq.com.

Aurora Cannabis and Radient Technologies Provide Update on Exclusive Collaboration

Aurora Cannabis and Radient Technologies Provide Update on Exclusive Collaboration

Aurora Cannabis and Radient Technologies Provide Update on Exclusive Collaboration

Aurora Cannabis and Radient Technologies Provide Update on Exclusive Collaboration

ArrangementsVANCOUVER, Feb. 13, 2017- Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Radient Technologies (“Radient”) (TSXV: RTI) are pleased to provide an update on their previously announced collaboration arrangements.

Project Update

As previously announced, the parties have entered into a memorandum of understanding (“MOU”) to evaluate an exclusive partnership for the Canadian market with regard to the joint development and commercialization of superior and standardized cannabinoid extracts.



Other Stories Buz Traders Follow

Aurora Cannabis

In accordance with the memorandum of understanding (“MOU”), the parties, on January 4, 2017, entered into a joint venture research agreement pursuant to which Radient and Aurora are working to confirm the effectiveness of Radient’s MAPTM technology for cannabis extraction. Initial results from the first phase of the study are encouraging. As a result, the parties have agreed to move to the second phase of the project, which includes preliminary scale-up activities. The second phase of work under the study has commenced and is expected to take approximately eight weeks.

“We are pleased with progress to date in assessing the feasibility of this potentially ground breaking extraction technology,” said Terry Booth, CEO. “The potential to substantially increase our extracts production capacity while maintaining terpene profiles would further differentiate our Company, and we are excited to be exploring this opportunity further in the coming weeks.”

Convertible Debenture

Aurora and Radient are also pleased to announce that Aurora has completed its investment in the Radient convertible debenture, announced initially on December 14, 2016 (the “Debenture”). The Debenture will have a principal amount of $2 million, a term of 2 years, bear interest at 10% per annum, and will be convertible into units of Radient at a conversion price of $0.14 per Unit. Each Unit will be comprised of one common share of Radient and one share warrant, exercisable within 24 months, for one common share of Radient at an exercise price of $0.33 per warrant. The Debenture will be repayable on demand from Aurora at any point within five months from the date of issuance.

Radient Private Placement

Additionally, Aurora intends to participate as lead investor in the private placement announced today by Radient.  The Company intends to invest up to $1.25 million in the offering. Units in the offering, priced at $0.45 each, are comprised of one common share of Radient and one half common share purchase warrant at a price of $0.70 per common share.

Denis Taschuk, President and CEO of Radient, stated “We are very encouraged with the initial positive results generated through the collective efforts of the Aurora and Radient teams, using our extraction expertise and technology for cannabis extraction, and we feel confident in meeting Aurora’s objectives. Additionally, the increasing corporate ties between Aurora and Radient and the funds raised provide us both with the resources and the ideal platform to implement our go to market strategy.”

About Aurora

Aurora’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, and is currently constructing a second 800,000 square foot, highly automated production facility at the Edmonton International Airport. Aurora trades on the TSX Venture Exchange under the symbol “ACB”.

About Radient

Radient extracts natural compounds from a range of biological materials using its proprietary MAPTM natural product extraction technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its initial 20,000 square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health, personal care and biofuel markets. Visit www.radientinc.com for more information.



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




FBEC Worldwide, Inc. Announces Exclusive Agreement with New Co-Packer NVE Pharmaceuticals, Developer of Stacker 2

$FBEC Announces Exclusive Agreement with New Co-Packer

FBEC Worldwide, Inc. Announces Exclusive Agreement with New Co-Packer NVE Pharmaceuticals, Developer of Stacker 2

FBEC Worldwide, Inc. Announces Exclusive Agreement with New Co-Packer NVE Pharmaceuticals, Developer of Stacker 2

FBEC Worldwide, Inc. (FBEC), a lifestyle brand company with a focus on Healthy Hemp Energy™ & CBD infused consumer products, is pleased to announce that on January 5, 2017 FBEC Worldwide, Inc. entered a new co-packing agreement with NVE Pharmaceuticals, the manufacturer of Stacker 2. NVE will produce FBEC’s proprietary 2oz energy shots using NVE’s custom ingredients and FBEC’s hemp juice powder.

CEO Jeff Greene stated, “NVE will allow us to increase production, quality & efficiency while reducing cost per bottle by up to 40% allowing for greater profit margins, for FBEC. NVE’s experience in the industry and the success & experience they have had with their product, Stacker 2, will no doubt be an asset as we move forward in 2017.”




Other Stories Buz Traders Follow

FBEC Worldwide

About NVE Pharmaceuticals:

NVE Pharmaceuticals is a leader in manufacturing herbal dietary supplements that have helped consumers with their diet and energy needs. NVE Pharmaceuticals, the Diet & Energy Specialists, continue to expand their reach into cutting edge research, development and private label manufacturing. Nationally known Stacker 2 and Stacker 3 commands a very strong and reliable presence in the market place today. Time proven success stories and exceptional manufacturing have been the cornerstone of the company. More info on NVE Pharmaceuticals: http://nveusa.com/

About FBEC Worldwide, Inc.

FBEC Worldwide, Inc. is a lifestyle Brand Company with a focus on Healthy Hemp Energy™ & CBD infused consumer products, both domestic and abroad. We are committed to increasing our market size and scope through the optics of creative marketing and most importantly customer satisfaction. Our growth strategies focus on several major initiatives, including unique branding opportunities that will be targeted at key demographic groups and to develop strong community and distributor relationships.

FBEC Worldwide is currently developing and building Healthy Hemp™ & CBD infused consumer products, focused on strong rates of growth within key fundamental consumer groups. Our company is dedicated to becoming the lead developer of name brand hemp & CBD infused consumer products.

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The Company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.

 

Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




PharmaCielo has signed an exclusive agreement with Cooperativa Caucannabis to jointly cultivate in the historic cannabis producing region of northeastern Cauca, Colombia.

PHARMACIELO SIGNS EXCLUSIVE AGREEMENT WITH COOPERATIVA CAUCANNABIS

PHARMACIELO SIGNS EXCLUSIVE AGREEMENT WITH COOPERATIVA CAUCANNABIS

PharmaCielo has signed an exclusive agreement with Cooperativa Caucannabis to jointly cultivate in the historic cannabis producing region of northeastern Cauca, Colombia.

PharmaCielo has signed an exclusive agreement with Cooperativa Caucannabis to jointly cultivate in the historic cannabis producing region of northeastern Cauca, Colombia.Formed in mid-2016, Cooperativa Caucannabis is a cooperative comprised of 53 regional farmers in the northeastern Cauca department from five communities: Corinto, Toribío, Miranda, Caloto and Jambaló. The mayors of these five communities, together with the full support of the Government of Colombia, encouraged the creation of this innovative initiative to eliminate illegal cannabis production and unite the region’s cultivators in an association that could apply for legal cultivation licensure under the terms of recently announced Colombian legislation.

 




 

Other Stories Buz Traders Follow

PharmaCielo has signed an exclusive agreement

 

“Regional partnership with Cooperativa Caucannabis is a reflection of our commitment to leading Colombia’s newly-formed cannabis industry in a way that should benefit all of Colombia,” said CEO Federico Cock-Correa. “As fellow Colombians, we believe that supporting small producers is essential to the economic health of local communities, the national economy and PharmaCielo alike.”Under the terms of the agreement, PharmaCielo and Cooperativa Caucannabis will jointly apply for cannabis cultivation licensing from the Government of Colombia. The agreement positions Cooperativa Caucannabis and its members to participate in Colombia’s legal cannabis industry by working together with PharmaCielo to cultivate cannabis that will be harvested for the purposes of producing standardized, medicinal-grade oil extracts and related products.The harvest gathered from the Cooperativa Caucannabis members will be in addition to existing contract grower relationships that PharmaCielo holds in the Rionegro region, and will significantly increase PharmaCielo’s overall cultivation and harvest volume.

As part of the agreement, PharmaCielo will purchase land in the region to construct a fully secure, scalable cultivation facility that will house open-air greenhouses similar to those currently operating at its nursery and propagation centre in Rionegro. The contract grower arrangement with Cooperativa Caucannabis will also enable PharmaCielo to access and propagate indigenous Colombian strains in their natural environment where they have become acclimatized over decades, and even centuries.

“PharmaCielo is proud to have the opportunity to work together with Cooperativa Caucannabis to develop sustainable, legal production in the northeastern Cauca region of Colombia. We took part, together with the farmers and governmental representatives, in several town hall meetings to ensure that all stakeholders’ interests were taken into consideration in this process. A former FARC stronghold ravaged by decades of conflict, the small cannabis farmers living in the war-torn towns and villages throughout this historic cannabis producing area of Colombia deserve to participate in Colombia’s newly legalized cannabis industry,” said Cock-Correa. “We look forward to developing additional strategic partnerships with regional associations of small producers throughout the country in the future and supporting the country’s post-conflict rebuilding efforts.”

Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Atlanta, Georgia Portfolio Company and First Hemp Lifestyle Network to Offer Cannabidiol (CBD) Products to Give Sneak Peak on New Products, Brand and Incentives

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Atlanta, Georgia

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Atlanta, Georgia

Portfolio Company and First Hemp Lifestyle Network to Offer Cannabidiol (CBD) Products to Give Sneak Peak on New Products, Brand and Incentives

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Atlanta, Georgia    Portfolio Company and First Hemp Lifestyle Network to Offer Cannabidiol <span data-recalc-dims=(CBD) Products to Give Sneak Peak on New Products, Brand and Incentives" width="300" height="196" srcset="https://i2.wp.com/investorsbuz.com/wp-content/uploads/2017/01/kannaway@2x-620x400.resized.jpg?resize=300%2C196 300w, https://i2.wp.com/investorsbuz.com/wp-content/uploads/2017/01/kannaway@2x-620x400.resized.jpg?w=640 640w" sizes="(max-width: 300px) 100vw, 300px" />

 Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary, Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding an exclusive Red Carpet Event in Atlanta, Ga., this weekend. The Red Carpet event provides a unique opportunity to network with top Kannaway leaders, the company’s executive team and fellow Kannaway business owners.

Attendees will hear from several executive team members, including Kannaway CEO Blake Schroeder, President Brad Tayles and CEO of Kannaway parent company Medical Marijuana, Inc., Dr. Stuart Titus. Additionally, the company will reveal important additions to the Kannaway brand, exciting changes to the incentive program and compensation plan and launch a new CBD Lifestyle Challenge.

“We are always excited to host our Kannaway Red Carpet Events as it is a chance for everyone to come together and learn more about the Kannaway system and immense possibilities afforded by being part of the Kannaway business,” Kannaway CEO Blake Schroeder said. “As the first Red Carpet Event in 2017, we will not only be providing exclusive pricing on our newly revamped products, but we will also be launching a new and improved formulation of one of our most popular CBD hemp oil products.”

The Atlanta Red Carpet Event is scheduled from 1 pm to 4 pm on Saturday, Jan. 14. Advance tickets to the Atlanta Red Carpet Event are available now for just $30. The day of the event, the price of tickets will increase to $40 at the door.

Prior to the Red Carpet Event, Kannaway will host a Business Opportunity Meeting. This meeting will run from 11:30 am to 12:30 pm the day of the show. There is no charge for this portion of the event, and interested prospects who attend can choose to buy a ticket to the ensuing Red Carpet Event.

About Kannaway, LLC
Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

 

Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




North Korea Missile Falls Into Japan’s Exclusive Economic Zone

North Korea Missile Falls Into Japan’s Exclusive Economic Zone

North Korea Missile Falls Into Japan’s Exclusive Economic Zone

North Korea Missile Falls Into Japan’s Exclusive Economic Zone

A North Korean ballistic missile fell for the first time into Japan’s exclusive economic zone early Wednesday, drawing strong condemnation from the government in Tokyo.

The missile, believed to be an intermediate-range Rodong type, flew about 1,000 kilometers (620 miles) before falling into waters about 250 kilometers from Japan’s coast line, according to South Korean and Japanese military officials. Kyodo news reported that the missile landed in waters to which Japan claims exclusive economic rights, and Prime Minister Shinzo Abe said later he believed that to be the case.

“This is a serious threat to our country’s security and is an intolerable act,” Abe told reporters in Tokyo. “We have made a strong protest to North Korea.”

Chief Cabinet Secretary Yoshihide Suga said that Japan would coordinate with South Korea and the U.S. and seek an appropriate response from the United Nations Security Council.